Proficio Capital Partners LLC Purchases New Position in Globe Life Inc. $GL

Proficio Capital Partners LLC bought a new stake in Globe Life Inc. (NYSE:GL) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 4,112 shares of the company’s stock, valued at approximately $735,000.

A number of other institutional investors and hedge funds have also made changes to their positions in GL. Hilton Head Capital Partners LLC bought a new position in shares of Globe Life in the 4th quarter valued at about $30,000. Johnson Financial Group Inc. bought a new stake in Globe Life during the second quarter worth approximately $39,000. CYBER HORNET ETFs LLC purchased a new stake in Globe Life during the second quarter valued at approximately $28,000. MUFG Securities EMEA plc purchased a new stake in Globe Life during the second quarter valued at approximately $31,000. Finally, Torren Management LLC bought a new stake in shares of Globe Life in the 4th quarter valued at approximately $37,000. 81.61% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Globe Life

In other Globe Life news, CEO Frank M. Svoboda sold 10,000 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $166.68, for a total transaction of $1,666,800.00. Following the transaction, the chief executive officer directly owned 54,020 shares in the company, valued at $9,004,053.60. This trade represents a 15.62% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Thomas Peter Kalmbach sold 25,650 shares of the company’s stock in a transaction on Tuesday, July 28th. The stock was sold at an average price of $178.58, for a total value of $4,580,577.00. Following the completion of the sale, the chief financial officer owned 50,568 shares of the company’s stock, valued at $9,030,433.44. This represents a 33.65% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 151,908 shares of company stock worth $27,239,981 over the last three months. Corporate insiders own 2.11% of the company’s stock.

Globe Life Trading Up 1.9%

NYSE GL opened at $175.56 on Thursday. The stock has a market cap of $13.49 billion, a PE ratio of 11.66 and a beta of 0.48. Globe Life Inc. has a 12 month low of $127.85 and a 12 month high of $191.55. The company’s 50-day moving average price is $178.63 and its 200-day moving average price is $159.23. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.43.

Globe Life (NYSE:GL) last announced its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). The company had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.59 billion. Globe Life had a net margin of 19.58% and a return on equity of 20.52%. The company’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $3.05 EPS. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Equities research analysts forecast that Globe Life Inc. will post 15.71 earnings per share for the current year.

Globe Life declared that its board has approved a share repurchase plan on Monday, August 10th that allows the company to buyback $2.50 billion in outstanding shares. This buyback authorization allows the company to buy up to 17.7% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s board believes its stock is undervalued.

Globe Life Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, October 5th will be paid a $0.33 dividend. The ex-dividend date of this dividend is Monday, October 5th. This represents a $1.32 annualized dividend and a yield of 0.8%. Globe Life’s dividend payout ratio is 8.76%.

Analyst Ratings Changes

Several analysts recently weighed in on the company. Jefferies Financial Group increased their price target on Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a report on Friday, July 10th. Wells Fargo & Company boosted their price objective on shares of Globe Life from $172.00 to $193.00 and gave the company an “overweight” rating in a research report on Thursday, July 9th. TD Cowen increased their target price on shares of Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a research note on Wednesday, July 22nd. Keefe, Bruyette & Woods lowered their target price on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating for the company in a report on Friday, July 24th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 21st. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $191.67.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.